David Gruber MD, MBA,
President, Healthcare Convergence Associates
Dr. Gruber is currently President, Healthcare Convergence Associates, a consulting firm focused on the tri-section of healthcare, the consumer, and digital media and technology.
He has had 25+ years of experience in healthcare as a Corporate executive, Wall Street analyst and physician.
Until December 2008, Dr. Gruber was Vice President, Corporate Development and New Ventures, J&J Consumer Group of Companies. His initial focus was in aesthetics, skin cancer and imaging. He subsequently spent the past few years focusing on the emergence of consumer-centric healthcare, and the role of enabling technology in fostering system change, consumer engagement and operational efficiency.
Until 2002, Dr. Gruber worked on Wall Street as a sellside and buyside analyst. He was a top-10 ranked analyst at Lehman Brothers covering medical device and supply companies, including Johnson & Johnson, Medtronic, Becton Dickinson and others. Dr. Gruber was the lead manager for the IPO’s of Intuitive Surgical and Given Imaging, as well as the lead analyst for a merchant banking investment in Therasense, subsequently sold to Abbott for $1.4 billion. These companies were among the most successful healthcare investments in the past decade.
Prior to entering Wall Street, Dr. Gruber was Vice President, Planning & Business Development in the $1.6B Healthcare Group at Bristol-Myers Squibb. He joined its ConvaTec division as a senior financial analyst following graduation from business school in 1986.
Dr. Gruber is a magna cum laude graduate of a six-year BS-MD program, having received his BS from CCNY and his MD from the Mt. Sinai School of Medicine. He also has an MBA from Columbia, and was a Kellogg Foundation National Fellow between1990-93. He is married and has four children.